HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans Vandekerckhove Selected Research

omecamtiv mecarbil

1/2024Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
1/2021Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
11/2020Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans Vandekerckhove Research Topics

Disease

4Heart Failure
01/2024 - 11/2020
1Obesity
07/2023
1Heart Diseases (Heart Disease)
01/2022
1Atrial Fibrillation
01/2022
1Systolic Heart Failure
01/2021
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Fabry Disease (Fabry's Disease)
01/2021
1Hepatitis
04/2012
1Myocarditis (Carditis)
04/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2010

Drug/Important Bio-Agent (IBA)

3omecamtiv mecarbilIBA
01/2024 - 11/2020
2Cardiac MyosinsIBA
01/2021 - 11/2020
1TroponinIBA
01/2024
1oxidized low density lipoproteinIBA
07/2023
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1Acetazolamide (Diamox)FDA LinkGeneric
01/2022
1DiureticsIBA
01/2022
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2020
1Natriuretic PeptidesIBA
11/2020
1sacubitril and valsartan sodium hydrate drug combinationIBA
11/2020
1EnzymesIBA
04/2012

Therapy/Procedure

3Therapeutics
01/2021 - 10/2010
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2021